RELATIVE BIOAVAILABILITY OF TWO FORMULATIONS OF THE SAME PROTON PUMP INHIBITOR AND HIGH POINT ESTIMATES ACHIEVED WITH DRUGS KNOWN TO EXHIBIT HIGH INTERINDIVIDUAL VARIANCES
15-21
Eva Peterfai, David J. Edwards, Klaus Stoeckel, Rolf F. Tiggemann
RESEARCH ARTICLE
Nobel Med 2006; 2(2): 15-21
